Loading news...
HSY, MCO, CBRE, MTD and ZBRA are five wide-moat leaders that combine solid growth outlooks and rising estimates to help fortify portfolios for steady returns.
Andra AP fonden grew its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 57.3% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 21,500 shares of the medical instruments supplier's stock after purchasing an additional 7,831 shares during the period. Andra AP fonden
Citigroup Inc. grew its holdings in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 4.8% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 65,033 shares of the medical instruments supplier's stock after acquiring an additional 2,989 shares during the quarter. Citigroup Inc.
Mettler-Toledo International, Inc. (NYSE: MTD - Get Free Report) has been given an average rating of "Hold" by the thirteen analysts that are covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among analysts that
Cibc World Market Inc. boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 12.3% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,419 shares of the medical instruments supplier's stock after purchasing an additional 375
Baader Bank Aktiengesellschaft lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 90.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 310 shares of the medical instruments supplier's stock after selling 2,997 shares during the
Candriam S.C.A. lessened its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 10.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,007 shares of the medical instruments supplier's stock after selling 3,184 shares during the quarter. Candriam S.C.A.
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sales: $1.1 billion for the quarter, an 8% increase on a US dollar reported basis.Local Currency Sales Growth: 5% increase, or 4% excluding acquisitions.Region
MTD beats Q4 estimates as adjusted EPS jumps 8% Y/Y and sales rise to $1.13B, led by solid growth across Laboratory, Industrial and Food Retail.
Mettler-Toledo International Inc. (MTD) Q4 2025 Earnings Call Transcript
Mettler-Toledo (MTD) came out with quarterly earnings of $13.36 per share, beating the Zacks Consensus Estimate of $12.76 per share. This compares to earnings of $12.41 per share a year ago.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior.
Besides Wall Street's top-and-bottom-line estimates for Mettler-Toledo (MTD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Thrivent Financial for Lutherans grew its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 752.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,586 shares of the medical instruments supplier's stock after acquiring an additional 64,951 shares during the quarter. Thrivent
Principal Financial Group Inc. boosted its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 2.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 298,429 shares of the medical instruments supplier's stock after purchasing an additional 8,360 shares during
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer (“CFO”) at STERIS plc (NYSE: STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined ST.
Massachusetts Financial Services Co. MA lowered its position in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 181,867 shares of the medical instruments supplier's stock after selling 14,738 shares during the quarter. Massachusetts
Representative Julia Letlow (R-Louisiana) recently sold shares of AbbVie Inc. (NYSE: ABBV). In a filing disclosed on January 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in AbbVie stock on December 8th. The trade occurred in the Representative's "MERRILL LYNCH INVESTMENT ACCOUNT #025" account. Representative Julia Letlow also recently made the following